-
-
-
-
-
-
-
Adial Pharmaceuticals gets 180-day extension to meet NASDAQ price rule
-
-
-
-
-
-
-
Adial Pharmaceuticals (ADIL) Files for 6.73M Share Offering by Selling Stockholders
-
-
-
-
-
-
-
Adial Pharmaceuticals (ADIL) Awarded New U.S. Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders
-
-
-
-
-
-
-
Adial Pharmaceuticals (ADIL) Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

